PRZ-ABIRATERONE
As listed in the register: PRZ-ABIRATERONE
250 mg · tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Abiraterone Acetate
- Made by
- Pharmaris Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States23 matching products
Bulgaria4 matching products
European UnionNo exact match for this strength and form
Spain13 matching products
- ABIRATERONA ACCORD 250 mg · comprimido
- ABIRATERONA ASHCURE 250 mg · comprimido recubierto con película
- ABIRATERONA FARMOZ 250 mg · comprimido
- ABIRATERONA FRESENIUS KABI 250 mg · comprimido
- ABIRATERONA GLENMARK 250 mg · comprimido
- ABIRATERONA OLPHA 250 mg · comprimido
- ABIRATERONA QILU 250 mg · comprimido
- ABIRATERONA STRAGEN 250 mg · comprimido
Netherlands17 matching products
- Abirateron Synthon 250 mg 250 mg · tablet3 makers
- Abirateron Amarox 250 mg filmomhulde tabletten 250 mg · filmomhulde tablet
- Abirateron AshCure 250 mg filmomhulde tabletten 250 mg · filmomhulde tablet
- Abirateron betapharm 250 mg 250 mg · tablet
- Abirateron CF 250 mg 250 mg · filmomhulde tablet
- Abirateron G.L. 250 mg 250 mg · tablet
- Abirateron MSN 250 mg filmomhulde tabletten 250 mg · filmomhulde tablet
- Abirateron Sandoz 250 mg 250 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Pharmaris Canada Inc |
|---|---|
| Active substance | Abiraterone Acetate |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 250 mg |
| Form | tablet |
| Classification | L02BX03 · Cancer treatments and immune-system medicines |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02540452 |
| DPD drug code | 102915 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet2 products
- 250 mg
- 500 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.